Real Chemistry Strengthens Position as Tier-One Healthcare Partner with 14% Year-Over-Year Growth in 2025
NEW YORK: Real Chemistry has announced its fiscal results for the year ending December 31, 2025, revealing a robust growth trajectory and reinforcing its role as a key commercialization partner for leading life sciences and healthcare organizations.
Shankar Narayanan, Chief Executive Officer, stated that the company is entering its 25th anniversary year in a strong position, with growth across all business segments. He emphasized that the company’s performance is a testament to its model tailored for the healthcare and life sciences sectors, which integrates AI-driven data, precision media strategy, and extensive creative execution. Narayanan noted ongoing investments in talent and technology aimed at enhancing client efficiency and measurable impact for healthcare providers, patients, and caregivers.
In 2025, the first full year following the spin-off of Swoop, Real Chemistry reported revenues of $560 million, marking a 14% increase from 2024. This growth continues an uninterrupted trend of year-over-year increases since the company’s inception in 2001. The company anticipates further acceleration in growth for 2026, fueled by investments in capabilities that meet critical client demands, strong interest in integrated solutions, and the expansion of precision media and analytics services.
Real Chemistry Expanded Capabilities and Global Reach
Throughout 2025, Real Chemistry enhanced its omnichannel business, solidifying its status as a preferred partner for delivering precision healthcare media experiences. The acquisitions of Spring & Bond and Greater Than One have broadened the company’s capacity to integrate data, media, creativity, and technology into comprehensive solutions for clients globally.
Real Chemistry has advanced its technology adoption by incorporating AI-enabled machine learning tools to transform workflows and expand client offerings. Notable tools include HealthGEO, a generative AI intelligence solution that provides a centralized view of brand representation, and the company’s proprietary omnichannel orchestration engine, which facilitates real-time personalization across digital channels.
Additionally, Real Chemistry has expanded its global presence with new hub offices in Munich, Zurich, and Dubai, with plans for further enhancements and team growth in 2026. The company’s international workforce has increased by 25% since 2023.
Changes in Healthcare Marketing Landscape
Jeff Lupinacci, Chief Financial Officer, highlighted that 2025 marked a significant shift in healthcare marketing and communications, as clients consolidated partnerships and raised expectations for efficient service delivery. He noted that Real Chemistry’s exclusive focus on healthcare and its streamlined operating model, supported by optimized global delivery and AI-driven workflows, enable effective execution that provides measurable value to clients.
Narayanan expressed confidence in the company’s momentum, stating that Real Chemistry is not just growing but strengthening its market position. He emphasized the importance of long-term partnerships and innovation to meet client needs in a complex market, ensuring sustained business retention and recognition of top talent through competitive incentives.
Industry Recognition in 2025
Real Chemistry received numerous accolades in 2025, reflecting the strength of its integrated model. The company was honored as Global Healthcare Agency of the Year by PRovoke and the SABRE Awards, as well as Outstanding Agency of the Year at the PRWeek Healthcare Awards. It was also named Healthcare Network of the Year by Medical Marketing + Media (MM+M) and Independent Healthcare Network of the Year by the London International Awards (LIA).
At the 2025 Cannes Lions Festival, Real Chemistry achieved a historic milestone by winning the first-ever Gold Lion for branded pharmaceutical work through its creative agency, 21GRAMS. The company was ranked as the No. 2 healthcare network and agency globally in the Cannes Lions Health rankings.
Real Chemistry has maintained its status as a Great Place to Work® for four consecutive years and was recognized on Fortune’s Best Places to Work in Advertising & Marketing list in 2025.
About Real Chemistry
Celebrating its 25th anniversary, Real Chemistry is a premier partner to innovative life sciences and healthcare companies. As a leading provider of AI-driven audience analytics and insights, the company assists the healthcare sector in understanding and engaging critical audiences to enhance the healthcare experience. With a culture rooted in innovation, Real Chemistry employs over 2,200 global experts focused on navigating the complexities of bringing scientific advancements to market.
Real Chemistry operates through offices in North America, Europe, and the Middle East, supported by a strategic partner network in Asia Pacific, Latin America, and Africa, enabling comprehensive client support worldwide.
For more information, visit www.realchemistry.com.
As reported by www.zawya.com.
